Hence, tanshinones could be developed as potential leads for AD treatment, as they are able to inhibit cholinesterase (AChE and BuChE) and nitric oxide–mediated neuroinflammation, which are the key pathological events of AD. This evidence concerns the gene ACHE and Alzheimer disease.